Articles

In the third year of treatment, both dose cohorts did not experience any contrast-enhancing lesions, and only a small population in the Barcelona center showed new T2 lesions.

Low-Dose Rituximab Safe, as Effective as High Dose in MS

Videos

Experts review the challenges of managing OFF episodes in Parkinson's disease and the current treatment options to optimize therapy. 

Optimal Management of OFF Episodes in Parkinson's Disease

Notably, no patients received a dose and route consistent with national guidelines.

Midazolam for Status Epilepticus Underutilized in EMS Setting Despite High Efficacy

The medical director manager of neuroscience at Genentech discussed the swath of data presented on the humanized anti-CD20 monoclonal antibody at MS Virtual.

Ocrelizumab Shows Range of Benefits for Spectrum of Patients With Multiple Sclerosis

Early intensive treatment was more effective in controlling disability progression over time compared with an escalation therapy approach.

Early Intensive MS Treatment Yields Better Outcomes Than Escalation Approach

The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.

Stephen L. Hauser, MD: Increasing Understanding of Disease Progression in MS

Patients with lower levels of disability tended to report fatigue as the most impactful symptom in daily life.

Fatigue Plays a Key Factor in Multiple Sclerosis Daily Functioning

The professor of neurology and pediatrics at University of Alabama at Birmingham Epilepsy Center discussed the FDA approval of epidiolex for patients with tuberous sclerosis complex. 

Martina Bebin, MD, MPA: Epidiolex and the Novelty of CBD in TSC

The results support continued development in Alzheimer disease and in patients with mid-stage Huntington disease who suffer from greater cognitive deficits.

Pepinemab Demonstrates Cognitive Benefit in Huntington Disease

David Dodick, MD, reviews changes to the treatment landscape for acute migraine. 

All News

New content coming soon, please check back later.